Clinical Study on the Effectiveness of Three Products in the Treatment of Herpes Simplex Labialis

Abstract

Herpes simplex labialis (HSL) is a viral disease that affects the perioral region. No guidelines recommending an effective treatment exist. The treatment of HSL with three different products was examined. Herpatch Serum, a film-forming patch, was compared to Compeed Patches, a set of semiocclusive hydrocolloid patches, and Zovirax Cream (ingredient: 5% acyclovir). In this prospective, randomized, examiner-blind study, 180 patients with recurrent HSL were split into three groups (Compeed: n = 60, Herpatch: n = 60, Zovirax: n = 60) and examined within 24 hours of HSL outbreak (DRKS Registration No.: DRKS00007786). The primary endpoint was healing time. The secondary endpoints were the reaction rate and quality of therapy evaluated by the Clinician's Global Assessment of Therapy (CGAT) and the Subject's Global Assessment of Therapy (SGAT) (0 = no response; 10 = excellent response), respectively. There was no significant difference among the healing times for the different products. The mean (95% confidence interval) was 9.67 days (9.11-10.22) for Compeed, 9.30 days (8.75-9.85) for Herpatch, and 9.80 days (9.30-10.30) for Zovirax. The reaction rate and quality of therapy (CGAT and SGAT) of Herpatch were significantly higher than those of Compeed and Zovirax. Within the study limitations, Herpatch proved to be an effective, non-antiviral alternative in the treatment of HSL.Herpes simplex labialis (HSL) is a worldwide infection of the oral and perioral regions caused by an infection with Herpes Simplex Virus type 1 (HSV-1) or, rarely, Herpes Simplex Virus type 2 (HSV-2). Despite the high prevalence of HSL, the disease has not yet been well characterized. The seroprevalence of HSV-1 in Germany was 78.4% from 2008 until 2011 1,2 . While many infections remain subclinical, other patients suffer from painful recurrent infections.Following the primary infection with HSV-1, the virus replicates at the site of infection and proceeds to travel retrograde down unmyelinated sensory fibres to the trigeminal ganglion, where it establishes latency 3 . Interfering triggers such as psychological or physiological stress, UVB radiation, trauma, menstruation, sideropenia or febrile illness can provoke the reactivation of the virus 4,5 .The course of disease in recurrent HSL generally involves several stages. Within the precursor stage, pain, tingling, or burning sensations in the affected area may occur. This is followed by the appearance of a macule, turning into a papule and leading to the formation of a vesicle. The vesicle bursts, and the formation of a soft scab is initiated. Subsequently, the soft scab is replaced by a hard scab. Over time, the scab falls off, and the lesion is fully healed without scarring 6-8 . While healing, the process is often accompanied by symptoms such as pain, discomfort or reduced self-esteem 6 . Complete healing takes seven to ten days 7 .The treatment of recurrent HSL turns out to be very difficult and variable. Because of the slight effects of diverse therapies, the infection represents a constant and...

A cost analysis and availability scenario of drugs and oral care products prescribed for common oral conditions with reference to the current Indian market prices, Jan Aushadhi, and the state medical commissions

“…It is to be noted that topical acyclovir is a more widely preferred formulation for managing Herpes labialis due to its ability to soothe pain, itching, and burning. [ 10 ] The inclusion of such commonly prescribed drugs has to be initiated to cut down the costs of receiving dental treatment.…”

Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex Mucocutaneous Infections and the Prevention of Recurrences: A Pilot Study

“…Satisfactory results have been achieved with other topical products, both synthetic and natural, in the treatment of herpes simplex mucocutaneous infections. Boes et al [ 33 ] compared three different products to treat herpes labialis in a randomized clinical trial: a film-forming patch, a set of semiocclusive hydrocolloid patches, and acyclovir 5% cream. The mean healing times (95% CI) in days were 9.30 (8.75–9.85), 9.67 (9.11–10.22), and 9.80 (9.30–10.30), respectively.…”

Transmisi Dan Reaktivasi Virus Herpes Simpleks Tipe 1 (Laporan Kasus)

“…(4) Selain terjadi reaktivasi, HSV-1 dapat ditularkan dari satu area ke area lain dalam satu penderita atau dari satu penderita ke penderita lainnya. (5,6) Penularan infeksi HSV pertama kali diteliti oleh Lipschutz pada tahun 1921. Penelitian tersebut menginokulasi lesi herpes dari genital ke kulit manusia yang dapat menimbulkan infeksi klinis bervariasi dari 24 jam hingga 72 jam.…”

“…Pemberian zat ini pada tahan prodromal dapat menyebabkan penghambatan replikasi HSV-1 dalam sel inang. (6) Efek dan manfaat pemberian aciclovir ini telah dibuktikan pada beberapa penelitian. Aciclovir juga mampu meningkatkan reepitelisasi dan mengurangi respon inflamasi.…”

“…Pemberian aciclovir topikal diwaktu yang tepat dinilai akan sangat efektif untuk mempercepat penyembuhan dan menghilangkan gejala. (6,19)…”